The Study of the Composition of Chloroform Fraction of Anemone nemorosa L.


  • Oksana Khropot
  • Yulian Konechnyi
  • Nataliya Polish
  • Roksolana Konechna
  • Yehor Bazavluk
  • Olena Kornіychuk
  • Volodymyr Novikov



Anemone nemorosa, chloroform fraction, gas chromatography, lipophilic extract, antimicrobial activity


Expanding the range of herbal drugs is among the priorities of the modern pharmacy. The analysis presented in this article is drawn from a broader qualitative study examining the composition of Anemone nemorosa L. chloroform fraction. The study revealed 38 compounds, and 32 of them were identified. The investigated lipophilic extract has an antimicrobial activity both in terms of gram-positive and gram-negative microorganisms. The maximal antimicrobial action of the investigated extract was shown to Escherichia coli. The significant content of biologically active substances in the lipophilic volatile fraction of Anemone nemorosa indicates the prospects for further study.


Lukianchuk A, Khropot O, Konechnyi Y, Konechna R, Novikov V. Wood anemone. Anemone Nemorosa L. Analytical review. ScienceRise: Pharmaceutical Science 2017;0(3 (7)):34-38.

Cumo CM. Encyclopedia of Cultivated Plants: From Acacia to Zinnia [3 Volumes]: From Acacia to Zinnia: ABC-CLIO, Santa Barbara, 1236 p. [homepage on the Internet]. Anemone (Wood); 1995-2017.

Mondoni A, Probert R, Rossi G, Hay F, Bonomi C. Habitat-correlated seed germination behaviour in populations of wood anemone (Anemone nemorosa L.) from northern Italy. Seed Science Research 2008;18(4):213-222.

Bobadilla Fazzini R, Skindersoe M, Bielecki P, Puchałka J, Givskov M, Martins dos Santos V. Protoanemonin: a natural quorum sensing inhibitor that selectively activates iron starvation response. Environmental Microbiology 2012;15(1):111-120.

Duan H, Zhang Y, Xu J, Qiao J, Suo Z, Hu G, Mu X. Effect of anemonin on NO, ET-1 and ICAM-1 production in rat intestinal microvascular endothelial cells. Journal of Ethnopharmacology 2006;104(3):362-366.

Huang Y, Lee T, Chan K, Hsu F, Wu Y, Lee M. Anemonin is a natural bioactive compound that can regulate tyrosinase-related proteins and mRNA in human melanocytes. Journal of Dermatological Science 2008;49(2):115-123.

Jia D, Han B, Yang S, Zhao J. Anemonin Alleviates Nerve Injury After Cerebral Ischemia and Reperfusion (I/R) in Rats by Improving Antioxidant Activities and Inhibiting Apoptosis Pathway. Journal of Molecular Neuroscience 2014;53(2):271-279.

Lee T, Huang N, Lai T, Yang A, Wang G. Anemonin, from Clematis crassifolia, potent and selective inducible nitric oxide synthase inhibitor. Journal of Ethnopharmacology 2008;116(3):518-527.

Roth L, Daunderer M, Kormann K. Giftpflanzen-Pflanzengifte, Auflage 4: Nikol Verlag, Hamburg, 1090 p.

Xiao K, Cao S, Jiao L, Lin F, Wang L, Hu C. Anemonin improves intestinal barrier restoration and influences TGF-β1 and EGFR signaling pathways in LPS-challenged piglets. Innate Immunity 2016;22(5):344-352.

Hao D, Gu X, Xiao P. Anemone medicinal plants: ethnopharmacology, phytochemistry and biology. Acta Pharmaceutica Sinica B 2017;7(2):146-158.

Martín M, Román L, Domínguez A. In VitroActivity of Protoanemonin, an Antifungal Agent. Planta Medica 1990;56(01):66-69.

Misra S, Dixit S. Antifungal principle ofRanunculus sceleratus. Economic Botany 1980;34(4):362-367.

Tsevegsüren N, Aitzetmüller K. γ-linolenic acid inAnemone spp. seed lipids. Lipids 1993;28(9):841-846. [homepage on the Internet]. Chervona knyha Ukrayiny; 2010-2017.

Kozoriz O. Likarski roslyny Karpat. Dykorosli ta kulturni: Mystetska Liniya, Uzhgorod, 504 p.

Hrodzinskyi M. Likarski roslyny: Entsyklopedychnyi dovidnyk: Vydavnytstvo “Ukrayinska Entsyklopediya” im. M.P. Bazhana, Kyiv, 544 p.

Magiorakos A, Srinivasan A, Carey R, Carmeli Y, Falagas M, Giske C, Harbarth S, Hindler J, Kahlmeter G, Olsson-Liljequist B, Paterson D, Rice L, Stelling J, Struelens M, Vatopoulos A, Weber J, Monnet D. Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. Clinical Microbiology and Infection 2012;18(3):268-281.